Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Reed

Showing results (531-540 of 900) with videos related to

Pageof 90
Sort By:
Therapeutic Innovation & Regulatory Science|May 2, 2018
Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference ResearchersAnne M Wolka, Angelyn O Fairchild, Shelby D Reed, et al.
Clinical Radiology|August 1, 1995
MRI T staging of squamous cell carcinoma of the oral cavity: radiological-pathological correlationR S Campbell, E Baker, A J Chippindale, et al.
Gastroenterology|July 14, 2007
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacyF Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Ophthalmology|June 5, 2007
Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau diseaseWai T Wong, Elvira Agrón, Hanna R Coleman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 15, 2013
Pathologic findings in lung allografts with anti-HLA antibodiesMatthew M DeNicola, Sam S Weigt, John A Belperio, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 29, 2013
Standardization and cross validation of alloreactive IFNγ ELISPOT assays within the clinical trials in organ transplantation consortiumI Ashoor, N Najafian, Y Korin, et al.
Psychopharmacology|November 7, 2018
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transportersAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
Psychiatric Services (Washington, D.C.)|March 17, 2015
Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia TreatmentBennett Levitan, Michael Markowitz, Ateesha F Mohamed, et al.
Cancer Medicine|July 19, 2025
Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple MyelomaJessie Sutphin, Thomas W LeBlanc, Ellen Janssen, et al.
Journal of Dairy Science|July 5, 2024
Greenhouse gas emissions and nutrient use efficiency assessment of 6 New York organic dairiesAgustin J Olivo, Olivia F Godber, Kristan F Reed, et al.
Pageof 90

Showing results (531-540 of 900) with videos related to

Sort By:
Pageof 90
Therapeutic Innovation & Regulatory Science|May 2, 2018
Effective Partnering in Conducting Benefit-Risk Patient Preference Studies: Perspectives From a Patient Advocacy Organization, a Pharmaceutical Company, and Academic Stated-Preference ResearchersAnne M Wolka, Angelyn O Fairchild, Shelby D Reed, et al.
Clinical Radiology|August 1, 1995
MRI T staging of squamous cell carcinoma of the oral cavity: radiological-pathological correlationR S Campbell, E Baker, A J Chippindale, et al.
Gastroenterology|July 14, 2007
Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacyF Reed Johnson, Semra Ozdemir, Carol Mansfield, et al.
Ophthalmology|June 5, 2007
Clinical characterization of retinal capillary hemangioblastomas in a large population of patients with von Hippel-Lindau diseaseWai T Wong, Elvira Agrón, Hanna R Coleman, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 15, 2013
Pathologic findings in lung allografts with anti-HLA antibodiesMatthew M DeNicola, Sam S Weigt, John A Belperio, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 29, 2013
Standardization and cross validation of alloreactive IFNγ ELISPOT assays within the clinical trials in organ transplantation consortiumI Ashoor, N Najafian, Y Korin, et al.
Psychopharmacology|November 7, 2018
Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transportersAmy J Eshleman, Shanthi Nagarajan, Katherine M Wolfrum, et al.
Psychiatric Services (Washington, D.C.)|March 17, 2015
Patients' Preferences Related to Benefits, Risks, and Formulations of Schizophrenia TreatmentBennett Levitan, Michael Markowitz, Ateesha F Mohamed, et al.
Cancer Medicine|July 19, 2025
Quantifying Preferences for CAR-T Compared to Standard of Care as a First-Line Treatment Among Patients With Multiple MyelomaJessie Sutphin, Thomas W LeBlanc, Ellen Janssen, et al.
Journal of Dairy Science|July 5, 2024
Greenhouse gas emissions and nutrient use efficiency assessment of 6 New York organic dairiesAgustin J Olivo, Olivia F Godber, Kristan F Reed, et al.
Pageof 90